Literature DB >> 27243349

Compliance and Subjective Patient Responses to Eyelid Hygiene.

Yousef A Alghamdi1, Andrew Camp, William Feuer, Carol L Karp, Sarah Wellik, Anat Galor.   

Abstract

OBJECTIVES: Lid hygiene is a commonly prescribed first-line therapy in patients with lid margin disease, yet compliance with therapy is not well characterized. The goals of this study were to assess patient compliance with lid hygiene and evaluate which factors predict a favorable symptomatic response to treatment.
METHODS: This was a cross-sectional study of patients seen in the Miami Veterans Affairs eye clinic between August and December 2014. An evaluation was performed to assess dry eye symptoms and lid margin signs. All patients were then instructed to perform warm compresses and lid scrubs. A follow-up phone survey assessed compliance and subjective therapeutic response 6 weeks later.
RESULTS: Two hundred seven of 211 (98%) patients (94% male, 60% white) completed the survey. Of the 207 patients, 188 (91%) completed the follow-up survey. Compliance with therapy was reported in 104 patients (55%); 66 reported complete improvement, 30 partial improvement, and 8 no improvement in symptoms. Patients who self-reported dry eye symptoms at first visit (n=86, 74%) were more likely to be compliant with lid hygiene than those who did not report symptoms (n=18, 25%) (P<0.0005). The only factor associated with poorer response to lid hygiene was longer time of self-reported dry eye symptoms. None of the other signs studied, including the presence of skin rosacea and lid margin telangiectasia, were associated with a differential response to lid hygiene.
CONCLUSIONS: Patients with dry eye symptoms were moderately compliant with lid hygiene, and patients who performed the routine noted improvement in symptoms.

Entities:  

Mesh:

Year:  2017        PMID: 27243349      PMCID: PMC5124421          DOI: 10.1097/ICL.0000000000000258

Source DB:  PubMed          Journal:  Eye Contact Lens        ISSN: 1542-2321            Impact factor:   2.018


  22 in total

1.  Neurovascular and neuroimmune aspects in the pathophysiology of rosacea.

Authors:  Verena D Schwab; Mathias Sulk; Stephan Seeliger; Pawel Nowak; Jerome Aubert; Christian Mess; Michel Rivier; Isabelle Carlavan; Patricia Rossio; Dieter Metze; Jörg Buddenkotte; Ferda Cevikbas; Johannes J Voegel; Martin Steinhoff
Journal:  J Investig Dermatol Symp Proc       Date:  2011-12

2.  Efficacy of a new warm moist air device on tear functions of patients with simple meibomian gland dysfunction.

Authors:  Yukihiro Matsumoto; Murat Dogru; Eiki Goto; Reiko Ishida; Takashi Kojima; Tatsuya Onguchi; Yukiko Yagi; Jun Shimazaki; Kazuo Tsubota
Journal:  Cornea       Date:  2006-07       Impact factor: 2.651

3.  Comparison of subjective grading and objective assessment in meibography.

Authors:  Heiko Pult; Britta Riede-Pult
Journal:  Cont Lens Anterior Eye       Date:  2012-10-27       Impact factor: 3.077

4.  Distribution of aqueous-deficient and evaporative dry eye in a clinic-based patient cohort: a retrospective study.

Authors:  Michael A Lemp; Leslie A Crews; Anthony J Bron; Gary N Foulks; Benjamin D Sullivan
Journal:  Cornea       Date:  2012-05       Impact factor: 2.651

5.  Evaluation of an automated thermodynamic treatment (LipiFlow®) system for meibomian gland dysfunction: a prospective, randomized, observer-masked trial.

Authors:  David Finis; Jasmin Hayajneh; Claudia König; Maria Borrelli; Stefan Schrader; Gerd Geerling
Journal:  Ocul Surf       Date:  2014-01-22       Impact factor: 5.033

6.  Ocular surface parameters in older male veterans.

Authors:  Anat Galor; William Feuer; David J Lee; Hermes Florez; Vincent D Venincasa; Victor L Perez
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-02-19       Impact factor: 4.799

7.  Disposable eyelid-warming device for the treatment of meibomian gland dysfunction.

Authors:  Asako Mori; Jun Shimazaki; Shigeto Shimmura; Hiroshi Fujishima; Yoshihisa Oguchi; Kazuo Tsubota
Journal:  Jpn J Ophthalmol       Date:  2003 Nov-Dec       Impact factor: 2.447

8.  Tear lipid layer structure and stability following expression of the meibomian glands.

Authors:  J P Craig; K Blades; S Patel
Journal:  Ophthalmic Physiol Opt       Date:  1995-11       Impact factor: 3.117

9.  Effect of oral linoleic and gamma-linolenic acid on meibomian gland dysfunction.

Authors:  Antonio Pinna; Paola Piccinini; Francesco Carta
Journal:  Cornea       Date:  2007-04       Impact factor: 2.651

Review 10.  Methodologies to diagnose and monitor dry eye disease: report of the Diagnostic Methodology Subcommittee of the International Dry Eye WorkShop (2007).

Authors: 
Journal:  Ocul Surf       Date:  2007-04       Impact factor: 5.033

View more
  10 in total

Review 1.  [Opinion of the BVA and the DOG on physical therapy of dry eye : July 2017 status].

Authors: 
Journal:  Ophthalmologe       Date:  2017-11       Impact factor: 1.059

2.  Bevacizumab Eye Drops Vs. Intra-meibomian Gland Injection of Bevacizumab for Meibomian Gland Dysfunction-Associated Posterior Blepharitis.

Authors:  Chitchanok Tantipat; Ngamjit Kasetsuwan; Patraramon Chotikkakamthorn; Krit Pongpirul
Journal:  Front Med (Lausanne)       Date:  2022-06-10

3.  Compliance with Lid Hygiene in Patients with Meibomian Gland Dysfunction.

Authors:  Varintorn Chuckpaiwong; Manachai Nonpassopon; Kaevalin Lekhanont; Weerapat Udomwong; Prae Phimpho; Nontawat Cheewaruangroj
Journal:  Clin Ophthalmol       Date:  2022-04-19

4.  The Efficacy Between Conventional Lid Hygiene and Additional Thermal Pulsatile System in Meibomian Gland Dysfunction Patients Treated with Long-Term Anti-Glaucoma Medications in a Randomized Controlled Trial.

Authors:  Ngamjit Kasetsuwan; Disorn Suwajanakorn; Chitchanok Tantipat; Usanee Reinprayoon
Journal:  Clin Ophthalmol       Date:  2020-09-28

5.  Short-Term Effects of a Novel Eye Mask Producing Heat and Vibration for the Treatment of Meibomian Gland Dysfunction: A Pilot Study.

Authors:  Luca Vigo; Marco Pellegrini; Francesco Carones; Vincenzo Scorcia; Giuseppe Giannaccare
Journal:  J Ophthalmol       Date:  2021-08-17       Impact factor: 1.909

6.  Improvement of Evaporative Dry Eye With Meibomian Gland Dysfunction in Model Mice by Treatment With Ophthalmic Solution Containing Mineral Oil.

Authors:  Keisuke Watanabe; Masataka Yoshida; Takashi Okumura; Takayuki Sassa; Akio Kihara; Akira Uchiyama
Journal:  Transl Vis Sci Technol       Date:  2021-04-01       Impact factor: 3.283

7.  How Long to Continue Eyelid Hygiene to Treat Meibomian Gland Dysfunction.

Authors:  Hyunmin Ahn; Bo Yi Kim; Jinyoung Kim; Yong Woo Ji; Ikhyun Jun; Tae-Im Kim; Hyung Keun Lee; Kyoung Yul Seo
Journal:  J Clin Med       Date:  2022-01-20       Impact factor: 4.241

Review 8.  Eyelid Warming Devices: Safety, Efficacy, and Place in Therapy.

Authors:  Brandon Bzovey; William Ngo
Journal:  Clin Optom (Auckl)       Date:  2022-08-05

9.  Transcutaneous Electrical Nerve Stimulation for the Long-Term Treatment of Ocular Pain.

Authors:  Kristen Zayan; Shruti Aggarwal; Elizabeth Felix; Roy Levitt; Konstantinos Sarantopoulos; Anat Galor
Journal:  Neuromodulation       Date:  2020-03-20

10.  TearCare for the Treatment of Meibomian Gland Dysfunction in Adult Patients With Dry Eye Disease: A Masked Randomized Controlled Trial.

Authors:  Preeya K Gupta; Edward J Holland; John Hovanesian; Jennifer Loh; Mitchell A Jackson; Paul M Karpecki; Kavita Dhamdhere
Journal:  Cornea       Date:  2022-04-01       Impact factor: 2.651

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.